EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

CCR5 predicts neurotoxicity in CAR ‐T‐cell therapy

Ayal Rozenberg iD, Shahar Shelly iD, Raz Winer, Riva Fineman, Shani Haller, Shimrit Ringelstein-Harlev iD, Israel Henig, Dana Yehudai-Ofir, Tsila Zuckerman iD, Tamar Tadmor iD, Reut Harel, Esther Ganelin-Cohen iD und 1 weitere

British Journal of Haematology · 2025

DOI: 10.1111/bjh.20228 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Haematology, 2025. Verfasst von Ayal Rozenberg und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Rambam Health Care Campus, Haifa, Israel. Hauptthemen laut MEDLINE: Receptors, CCR5, Neurotoxicity Syndromes, Immunotherapy, Adoptive. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, CCR5Neurotoxicity SyndromesImmunotherapy, AdoptiveHumansMaleFemaleCD4-Positive T-LymphocytesMiddle AgedBiomarkersReceptors, Chimeric AntigenAdultReceptors, CCR2Aged

Stichwörter der Autor:innen

CAR‐T cellsICANSchemokineslymphomasmacrophages

Substanzen

Receptors, CCR5CCR5 protein, humanBiomarkersReceptors, Chimeric AntigenReceptors, CCR2CCR2 protein, human

Autor:innen und Institutionen

  • Department of Neurology, Rambam Health Care Campus, Haifa, Israel.
  • Neuroimmunology Laboratory, Ruth and Bruce Rapaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.
  • Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel.
  • Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel.
  • Department of Hemathology, Bnai Zion Medical Center, Haifa, Israel.
  • Department of Hemathology, Emek Medical Center, Afula, Israel.

ORCID-Profile: Ayal Rozenberg, Shahar Shelly, Shimrit Ringelstein-Harlev, Tsila Zuckerman, Tamar Tadmor, Esther Ganelin-Cohen

Zitieren

APA

Rozenberg, A., Shelly, S., Winer, R., Fineman, R., Haller, S., Ringelstein-Harlev, S., Henig, I., Yehudai-Ofir, D., Zuckerman, T., Tadmor, T., Harel, R., Ganelin-Cohen, E., & Beyar-Katz, O. (2025). CCR5 predicts neurotoxicity in CAR ‐T‐cell therapy. British Journal of Haematology. https://doi.org/10.1111/bjh.20228

Vancouver

Rozenberg A, Shelly S, Winer R, Fineman R, Haller S, Ringelstein-Harlev S, et al. CCR5 predicts neurotoxicity in CAR ‐T‐cell therapy. British Journal of Haematology. 2025. doi:10.1111/bjh.20228

BibTeX
@article{Rozenberg2025,
  author = {Rozenberg, Ayal and Shelly, Shahar and Winer, Raz and Fineman, Riva and Haller, Shani and Ringelstein-Harlev, Shimrit and Henig, Israel and Yehudai-Ofir, Dana and Zuckerman, Tsila and Tadmor, Tamar and Harel, Reut and Ganelin-Cohen, Esther and Beyar-Katz, Ofrat},
  title = {CCR5 predicts neurotoxicity in CAR ‐T‐cell therapy},
  journal = {British Journal of Haematology},
  year = {2025},
  doi = {10.1111/bjh.20228}
}
Kostenlos starten →